Randomised Placebo Controlled Trial of a Parenteral Modified Cobratoxin in Adrenomyeloneuropathy

Registry ID

EUCTR2004-002200-14

Source registry

EUCTR

Status

Completed

Phase

PHASE3

Sponsor

ReceptoPharm Inc.

Start date

2006-04-19

Completion date

2008-08-21

Last update

2026-08-16

Conditions

• Adrenomyeloneuropathy

Summary

This Study Aims to Assess the Safety and Efficacy of Modified Cobratoxin on the Motor Function in Patients with Symptomatic Adrenomyeloneuropathy.

Locations

• , , UK

Related clinical trials

• The Myelin Disorders Biorepository Project
• Modeling Macrophages Activation Pattern in X-linked Adrenoleukodystrophy, Metachromatic Leukodystrophy and Adult Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia
• Home Exercise for Individuals with Neurodegenerative Disease

View on source registry